The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
